A detailed history of Barclays PLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Barclays PLC holds 452,356 shares of IDXX stock, worth $186 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
452,356
Previous 452,356 -0.0%
Holding current value
$186 Million
Previous $229 Million -0.0%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$455.08 - $517.19 $94.1 Million - $107 Million
206,677 Added 84.12%
452,356 $229 Million
Q2 2024

Aug 14, 2024

SELL
$468.04 - $548.53 $37.1 Million - $43.4 Million
-79,182 Reduced 24.37%
245,679 $120 Million
Q1 2024

May 15, 2024

BUY
$515.08 - $576.87 $8.91 Million - $9.98 Million
17,305 Added 5.63%
324,861 $175 Million
Q4 2023

Feb 15, 2024

BUY
$391.37 - $557.56 $23.1 Million - $32.9 Million
59,080 Added 23.78%
307,556 $171 Million
Q3 2023

Nov 07, 2023

BUY
$432.42 - $556.67 $34.2 Million - $44 Million
79,102 Added 46.7%
248,476 $109 Million
Q2 2023

Aug 03, 2023

BUY
$450.7 - $503.61 $37.3 Million - $41.7 Million
82,862 Added 95.78%
169,374 $85.1 Million
Q1 2023

May 04, 2023

SELL
$406.01 - $514.59 $12 Million - $15.2 Million
-29,612 Reduced 25.5%
86,512 $43.3 Million
Q4 2022

Feb 13, 2023

BUY
$324.64 - $441.27 $8.29 Million - $11.3 Million
25,527 Added 28.18%
116,124 $47.4 Million
Q3 2022

Nov 03, 2022

SELL
$325.8 - $407.78 $2.11 Million - $2.64 Million
-6,475 Reduced 6.67%
90,597 $29.5 Million
Q2 2022

Aug 12, 2022

SELL
$327.37 - $553.44 $12.1 Million - $20.5 Million
-37,041 Reduced 27.62%
97,072 $34 Million
Q1 2022

May 16, 2022

SELL
$466.52 - $631.01 $18.3 Million - $24.8 Million
-39,272 Reduced 22.65%
134,113 $73.4 Million
Q4 2021

Feb 14, 2022

BUY
$586.54 - $666.48 $7.14 Million - $8.12 Million
12,176 Added 7.55%
173,385 $114 Million
Q3 2021

Nov 09, 2021

BUY
$621.9 - $705.76 $13.8 Million - $15.6 Million
22,128 Added 15.91%
161,209 $100 Million
Q2 2021

Aug 13, 2021

BUY
$486.36 - $637.08 $1.75 Million - $2.3 Million
3,606 Added 2.66%
139,081 $87.8 Million
Q1 2021

May 13, 2021

BUY
$465.18 - $551.79 $1.93 Million - $2.29 Million
4,146 Added 3.16%
135,475 $66.3 Million
Q4 2020

Feb 11, 2021

BUY
$383.85 - $499.87 $8.92 Million - $11.6 Million
23,238 Added 21.5%
131,329 $65.6 Million
Q3 2020

Nov 12, 2020

SELL
$334.54 - $406.31 $3.49 Million - $4.24 Million
-10,444 Reduced 8.81%
108,091 $42.5 Million
Q2 2020

Aug 12, 2020

SELL
$230.66 - $330.16 $6.1 Million - $8.73 Million
-26,431 Reduced 18.23%
118,535 $39.1 Million
Q1 2020

May 13, 2020

SELL
$182.94 - $290.97 $4.87 Million - $7.75 Million
-26,620 Reduced 15.51%
144,966 $35.1 Million
Q4 2019

Feb 10, 2020

BUY
$248.66 - $285.01 $3.67 Million - $4.21 Million
14,771 Added 9.42%
171,586 $44.8 Million
Q3 2019

Nov 14, 2019

BUY
$260.07 - $289.93 $5.79 Million - $6.46 Million
22,272 Added 16.55%
156,815 $42.6 Million
Q2 2019

Aug 14, 2019

SELL
$215.53 - $275.33 $2.43 Million - $3.1 Million
-11,276 Reduced 7.73%
134,543 $37 Million
Q1 2019

May 15, 2019

BUY
$178.02 - $225.69 $2.24 Million - $2.84 Million
12,581 Added 9.44%
145,819 $32.6 Million
Q4 2018

Feb 14, 2019

SELL
$176.18 - $248.92 $6.59 Million - $9.31 Million
-37,413 Reduced 21.92%
133,238 $24.8 Million
Q3 2018

Nov 14, 2018

BUY
$218.82 - $254.46 $14.7 Million - $17 Million
66,962 Added 64.58%
170,651 $42.6 Million
Q2 2018

Aug 14, 2018

SELL
$185.56 - $227.9 $4.99 Million - $6.13 Million
-26,898 Reduced 20.6%
103,689 $22.6 Million
Q1 2018

May 15, 2018

BUY
$157.81 - $204.73 $2.6 Million - $3.37 Million
16,448 Added 14.41%
130,587 $25 Million
Q4 2017

Feb 14, 2018

BUY
$147.68 - $168.37 $7.2 Million - $8.21 Million
48,773 Added 74.62%
114,139 $17.8 Million
Q3 2017

Nov 14, 2017

BUY
$150.32 - $166.46 $9.83 Million - $10.9 Million
65,366
65,366 $10.2 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.3B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.